POLSINELLI PC for TEVA PHARMACEUTICALS USA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 133, FY2021 Omnibus and COVID Relief and Response Act Review of Administration drug pricing and telehealth policies
Foreign entity interest: Teva Pharmaceutical Industries LTD, as the indirect parent of TEVA Pharmaceuticals USA INC, has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DALEY | — |
| SYLVIA STANOJEV KORNEGAY | — |
| TIM PERRIN | — |
| HARRY ANASTASIOS SPORIDIS | — |
| STEVEN STRANNE | — |
| ALAN WHEAT | — |
Health Issues HCR
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 133, FY2021 Omnibus and COVID Relief and Response Act Review of Administration drug pricing and telehealth policies
Foreign entity interest: Teva Pharmaceutical Industries LTD, as the indirect parent of TEVA Pharmaceuticals USA INC, has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DALEY | — |
| SYLVIA STANOJEV KORNEGAY | — |
| TIM PERRIN | — |
| HARRY ANASTASIOS SPORIDIS | — |
| STEVEN STRANNE | — |
| ALAN WHEAT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.